newsfilter
← Latest News
GlobeNewswire·

Cytek Aurora® Evo System Wins BioTech Breakthrough Award for Drug Discovery Innovation of the Year

  • Cytek Biosciences Inc. (Nasdaq: CTKB) announced that its Cytek Aurora Evo system received the Drug Discovery Innovation of the Year award at the 2026 BioTech Breakthrough Awards.
  • The system addresses industry demands for higher throughput, greater automation, & consistent data quality in pharmaceutical & contract research organization (CRO) workflows.
  • Built on Full Spectrum Profiling™ technology, the Aurora Evo reduces acquisition time by approximately 40% for plate well workflows compared to earlier generations.
  • Automated startup & shutdown features reduce operator intervention & extend instrument utilization beyond standard work hours to increase screening capacity.
  • The platform incorporates instrument harmonization to minimize variability across systems, laboratories, & time, facilitating easier assay transfers between locations.
  • Future development includes a path toward automated sample processing using robotic arms to further enhance efficiency for large sample volumes.
  • CEO Wenbin Jiang stated the recognition reflects the company's commitment to advancing flow cytometry to meet evolving researcher needs.
  • Cytek Biosciences is headquartered in Fremont, California, & operates global offices with a product suite including the Aurora, Northern Lights, & Muse systems.
Company
Cytek Biosciences, Inc.
Keywords
Nasdaq:CTKB, Cytek Biosciences, Inc., BioTech Breakthrough Awards, drug discovery solution, drug discovery innovation, flow cytometry, spectral flow cytometry